Investing.com - Avita Medical (NASDAQ: RCEL) reported fourth quarter EPS of $-0.21, $0.03 better than the analyst estimate of $-0.24. Revenue for the quarter came in at $9.46M versus the consensus estimate of $8.8M.
Avita Medical's stock price closed at $9.06. It is up 35.43% in the last 3 months and up 1.23% in the last 12 months.
Avita Medical saw 4 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Avita Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Avita Medical's Financial Health score is "great performance".
Check out Avita Medical's recent earnings performance, and Avita Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar